Conclusion β_2-agonist and glucocorticosteroid should be inhaled in patients with bronchiectasia and reversible airflow limitation to block the airflow limitation and decrease the quantity of sputum draining, and they are also beneficial to the control of infection. 结论:支气管扩张患者并发可逆性气流受限患者应当吸入β2受体激动剂和糖皮质激素治疗,以阻断气流受限,明显减少痰量,利于感染的控制。
One hundred and forty patients with bronchitis, pneumonia, bronchial asthma, bronchiectasia, etc. were enrolled in the trial and among them 4 patients were eliminated and 136 patients for efficacy evaluation. 共入组140例支气管炎、肺炎、支气管哮喘、支气管扩张病人,剔除4例,进入疗效分析136例,其中试验组67例,对照组69例。